WWW.DISSERTATION.XLIBX.INFO
FREE ELECTRONIC LIBRARY - Dissertations, online materials
 
<< HOME
CONTACTS



Pages:   || 2 | 3 | 4 |

«Model TPO100 Model TPO100B Dealer: This manual MUST be given to the end user. 0120 User: BEFORE using this product, read this manual and save for ...»

-- [ Page 1 ] --

User Manual

Invacare SOLO2™

Transportable

Oxygen Concentrator

Model TPO100

Model TPO100B

Dealer: This manual MUST be given to the end

user.

0120

User: BEFORE using this product, read this

manual and save for future reference.

For more information regarding Invacare

products, parts, and services, please visit

www.invacare.com

WARNING

DO NOT USE THIS PRODUCT OR ANY

AVAILABLE OPTIONAL EQUIPMENT WITHOUT

FIRST COMPLETELY READING AND

UNDERSTANDING THESE INSTRUCTIONS AND

ANY ADDITIONAL INSTRUCTIONAL MATERIAL

SUCH AS USER MANUALS, SERVICE MANUALS

OR INSTRUCTION SHEETS SUPPLIED WITH

THIS PRODUCT OR OPTIONAL EQUIPMENT. IF

YOU ARE UNABLE TO UNDERSTAND THE

WARNINGS, CAUTIONS OR INSTRUCTIONS,

CONTACT A HEALTHCARE PROFESSIONAL,

DEALER OR TECHNICAL PERSONNEL BEFORE

ATTEMPTING TO USE THIS EQUIPMENT -

OTHERWISE, INJURY OR DAMAGE MAY OCCUR.

ACCESSORIES WARNING

INVACARE PRODUCTS ARE SPECIFICALLY

DESIGNED AND MANUFACTURED FOR USE IN

CONJUNCTION WITH INVACARE ACCESSORIES.

ACCESSORIES DESIGNED BY OTHER

MANUFACTURERS HAVE NOT BEEN TESTED BY

INVACARE AND ARE NOT RECOMMENDED FOR

USE WITH INVACARE PRODUCTS.

NOTE: Updated versions of this manual can be found at www.invacare.com.

Invacare SOLO2™ 2 Part No 1156872

TABLE OF CONTENTS

SPECIAL NOTES

Disposal of Equipment and Accessories

SECTION 1—GENERAL GUIDELINES

Operating Information

Maintenance

Radio Frequency Interference

Polarized Plug Instruction

SECTION 2—PACKAGING AND HANDLING

Unpacking

Inspection

Storage

SECTION 3—TECHNICAL DESCRIPTION

SECTION 4— FEATURES

SECTION 5—TYPICAL PRODUCT PARAMETERS

Regulatory Listing

SECTION 6—OPERATING INSTRUCTIONS

Location

Recommendations for Optimal Performance

Filters

Powering the Transportable Oxygen Concentrator

Installing the Battery Module

Charging the Battery

Battery Time Management

Checking Battery Charge Level

Prolonging Battery Life

Connecting/Positioning the Nasal Cannula

Connecting the Humidifier

Transportable Oxygen Concentrator Front Panel and LCD Display

Using the SOLO2 Transportable Oxygen Concentrator

SECTION 7—CLEANING, CARE, AND MAINTENANCE................32 Cabinet

Air Intake Filter

Cleaning the Cannula

Cleaning the Humidifier

Transportable Oxygen Concentrator Preventative Maintenance Record..................34 SECTION 8—TROUBLESHOOTING GUIDE

Troubleshooting

Warnings and Alarms

SECTION 9—OPTIONAL ACCESSORIES

LIMITED WARRANTY

EUROPEAN CONTACTS

Part No 1156872 3 Invacare SOLO2™

SPECIAL NOTES

SPECIAL NOTES

Signal words are used in this manual and apply to hazards or unsafe  practices which could result in personal injury or property damage. Refer  to the following table for definitions of the signal words.

–  –  –

NOTICE The information contained in this document is subject to change without  notice.

DANGER DO NOT SMOKE while using this device. Keep all  matches, lit cigarettes, candles or other sources of ignition  out of the room in which this product is located and away  from where oxygen is being delivered.

NO SMOKING signs should be prominently displayed.  Textiles and other materials that normally would not burn  are easily ignited and burn with great intensity in oxygen  enriched air. Failure to observe this warning can result in  severe fire, property damage and cause physical injury or  death.

Invacare SOLO2™ 4 Part No 1156872

SPECIAL NOTES

CAUTION

Within the US:

“Caution: Federal law restricts this device to sale or rental by  or on order of a physician, or any other practitioner licensed  by the law of the State in which he/she practices to use or  order the use of this device.” The use of oxygen therapy in certain circumstances can be  hazardous and seeking medical advice before using this  device is advisable.

Invacare recommends an alternate source of supplemental  oxygen in the event of a power outage, alarm condition or  mechanical failure. Consult your physician or equipment  provider for the type of reserve system required.





This equipment is to be used as an oxygen supplement and is  not considered life supporting or life sustaining.

Outside the US:

“Caution: Statutory law can restrict this device to sale or  rental by or on order of a physician, or any other practitioner  licensed by the law of the government agency in which  he/she practices to use or order the use of this device.” Invacare recommends an alternative source of supplemental  oxygen in the event of a power outage, alarm condition or  mechanical failure. Consult our physician or equipment  provider of r the type of reserve system required.

This equipment is to be used as an oxygen supplement and is  not considered life supporting or life sustaining.

Part No 1156872 5 Invacare SOLO2™SPECIAL NOTES

Disposal of Equipment and Accessories This product has been supplied from an environmentally aware  manufacturer that complies with the Waste Electrical and Electronic  Equipment (WEEE) Directive 2002/96/CE. This product may contain  substances that could be harmful to the environment if disposed of in  places (landfills) that are not appropriate according to legislation.

Follow local governing ordinances and recycling plans regarding disposal  of the device or components normally used in operation. The device does  not generate waste or residue in operation. DO NOT dispose of the device  or the battery module in the normal waste stream. The lithium battery  module should be returned to your dealer/provider for recycling. Any  accessories not part of the device MUST be handled in accordance with the  individual product marking for disposal.

–  –  –

SECTION 1—GENERAL GUIDELINES In order to ensure the safe installation, assembly and  operation of the transportable oxygen concentrator these  instructions MUST be followed.

WARNING This section contains important information for the safe  operation and use of this product.

DANGER Risk of electric shock. DO NOT disassemble. Refer  servicing to qualified service personnel. No user  serviceable parts.

TO REDUCE THE RISK OF BURNS, ELECTROCUTION, 

FIRE OR INJURY TO PERSONS

A spontaneous and violent ignition may occur if oil, grease,  greasy substances, or petroleum based products come in  contact with oxygen under pressure. These substances  MUST be kept away from the transportable oxygen  concentrator, tubing and connections, and all other oxygen  equipment. DO NOT use any lubricants unless  recommended by Invacare.

Avoid using while bathing. If continuous usage is required  by the physician’s prescription, the concentrator MUST be  located in another room at least 7 ft (2.1 m) from the bath.

DO NOT come in contact with the concentrator while wet.

DO NOT place or store product where it can drop into  water or other liquid.

DO NOT reach for product that has fallen into water.  Unplug IMMEDIATELY.

Keep the oxygen tubing, cord, and unit out from under  such items as blankets, bed coverings, chair cushions,  clothing and away from heated or hot surfaces, including  space heaters, stoves and similar electrical appliances. 

–  –  –

DANGER Avoid creation of any spark near medical oxygen  equipment. This includes sparks from static electricity  created by any type of friction.

DO NOT move or relocate concentrator by pulling on the  cord.

A product should NEVER be left unattended when plugged  in. Make sure the transportable oxygen concentrator is Off  when not in use.

Outdoor use of the transportable oxygen concentrator MUST  be conducted with battery power only.  Operating Information The transportable oxygen concentrator can only be used in  conjunction with PAP, Bi‐Level or other such devices when in  continuous flow mode.

If the transportable oxygen concentrator is not working  properly, if it has been dropped or damaged, or dropped into  water, call equipment provider/qualified technician for  examination and repair.  If you feel ill or uncomfortable, or if the unit does not signal  an oxygen pulse and you are unable to hear and/or feel the  oxygen pulse while in pulse flow mode or you cannot hear or  feel flow when in continuous flow mode, consult your  equipment provider and/or your physician IMMEDIATELY.

NEVER drop or insert any object or liquid into any opening.

DO NOT use extension cords with AC power adaptors  provided.

For optimum performance, Invacare recommends that each  concentrator be on and running for a minimum of 5 minutes.  Shorter periods of operation may reduce maximum product  life.

Invacare SOLO2™ 8 Part No 1156872 SECTION 1—GENERAL GUIDELINES The transportable oxygen concentrator is designed only to be  used with a humidifier while using continuous flow mode.  Use of this device with a humidifier in pulse flow mode may  impair performance and/or damage the equipment.

When your automobile is turned Off, disconnect the car  accessory power supply and remove the transportable  oxygen concentrator from the automobile. NEVER allow the  transportable oxygen concentrator to be stored in a very hot  or cold automobile or in other similar, high or low,  temperature environments. Refer to Typical Product  Parameters on page 14.

DO NOT operate in temperatures below 41° F (5°C) or above  104° F (40° C) for extended periods of time.

Invacare recommends that the battery module be removed  from the unit when the unit is not intended to be used for  extended periods of time.

DO NOT connect the concentrator in parallel or series with  other oxygen concentrators or oxygen therapy devices.

Invacare recommends that the transportable oxygen  concentrator not be used for extended periods in the rain.

Close supervision is necessary when this product is used  near children or physically‐challenged individuals.

Additional monitoring or attention may be required for  patients using this device who are unable to hear or see  alarms or communicate discomfort.  Be aware that electrical cords and/or tubing could present a  tripping hazard.

A change in altitude may affect total oxygen available to you.  Consult your physician before traveling to altitudes above  10,000 ft (3046 m) to determine if your flow settings should  be changed.

Part No 1156872 9 Invacare SOLO2™ SECTION 1—GENERAL GUIDELINES Maintenance The transportable oxygen concentrator was specifically  designed to minimize routine preventive maintenance. Only  professionals of the healthcare field or persons fully  conversant with this process such as factory trained  personnel should perform preventive maintenance or  performance adjustments on the oxygen concentrator.  Radio Frequency Interference This equipment has been tested and found to comply with  EMC limits specified by IEC/EN 60601‐1‐2. These limits are  designed to provide a reasonable protection against  electromagnetic interference in a typical medical installation.

Other devices may experience interference from even the low  levels of electromagnetic emissions permitted by the above  standards. To determine if the emissions from the  transportable oxygen concentrator are causing the  interference, turn the transportable oxygen concentrator Off.  If the interference with the other device(s) stops, then the  transportable oxygen concentrator is causing the  interference. In such rare cases, interference may be reduced 

or corrected by one of the following measures:

• Reposition, relocate, or increase the separation  between the equipment.

• Connect the equipment into an outlet on a circuit  different from that to which the other device(s) is  connected.



Pages:   || 2 | 3 | 4 |


Similar works:

«Package leaflet: Information for the patient Vanatex HCT 80 mg/12.5 mg film-coated tablets Vanatex HCT 160 mg/12.5 mg film-coated tablets Vanatex HCT 160 mg/25 mg film-coated tablets Valsartan/hydrochlorothiazide Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.Keep this leaflet. You may need to read it again.If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only....»

«The Intractable Pain Patient’s Handbook for Survival by Forest Tennant, MD, DrPH The Intractable Pain Patient’s Handbook for Survival by Forest Tennant, MD, DrPH © Copyright 2007 Forest Tennant, MD, DrPH VERACT INTRACTABLE PAIN CLINIC 340 South Glendora Avenue; West Covina, CA 91790-3043 626-919-7476; E-mail: veractinc@msn.com; Website: www.intractablepaindisease.com Published by Pain Treatment Topics Glenview, IL, USA http://www.Pain-Topics.org (cover revision June 2007) The mission of...»

«16 Chronic Periaortitis as a Systemic Autoimmune Disease Chang-Hee Suh Rheumatology, Ajou University School of Medicine Korea 1. Introduction Chronic periaortitis is an idiopathic disease whose hallmark is the presence of a fibroinflammatory tissue arising from the adventitia of the abdominal aorta and the common iliac arteries and extending into the surrounding retroperitoneum and frequently encasing neighboring structures such as the ureters and the inferior vena cava (Mitchinson, 1984;...»

«WARNINGS AND PRECAUTIONS HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use  Activities requiring mental alertness: Avoid engaging in activities DICLEGIS safely and effectively. See full prescribing information for requiring complete mental alertness, such as driving or operating heavy DICLEGIS. machinery, while using DICLEGIS until cleared to do so by a healthcare DICLEGIS (doxylamine succinate and pyridoxine hydrochloride) provider...»

«ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Plenadren 5 mg modified-release tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each modified-release tablet contains hydrocortisone 5 mg. For a full list of excipients, see section 6.1.3. PHARMACEUTICAL FORM Modified-release tablet. The tablets are round (diameter 8 mm), convex and pink. 4. CLINICAL PARTICULARS 4.1 Therapeutic indications Treatment of adrenal insufficiency in adults. 4.2 Posology and method of...»

«On the Physical Death of Jesus Christ William D. Edwards, MD; Wesley J. Gabel, MDiv; Floyd E. Hosmer, MS, AMI Jesus of Nazareth underwent Jewish and Roman trials was flogged and was sentenced to death by crucifixion. The scourging produced deep stripelike lacerations and appreciable blood loss and it probably set the stage for hypovolemic shock as evidenced by the fact that Jesus was too weakened to carry the crossbar (patibulum) to Golgotha. At the site of crucifixion his wrists were nailed to...»

«Solo System ® User Manual Form 94006 May 29, 2002 / ISO Reference 7.2.2 DEVICE Congratulations! You are now the owner of a Sunlighten sauna! Are you ready to experience ultimate relaxation and rejuvenation? Just follow our assembly and usage guidelines and you will soon be in Sunlighten heaven!DISCLAIMER: The Solo System® is a Personal Sauna. Any information presented within this manual is for educational or reference purposes only. The content of this manual is not intended for diagnosis or...»

«Domestic Water Quantity, Service, Level and Health © World Health Organization 2003 The illustration of the cover page is extracted from Rescue Mission: Planet Earth, © Peace Child International 1994; used by permission All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for...»

«Filed electronically on 6/27/16 via http://www.regulations.gov June 27, 2016 Mr. Andy Slavitt, Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-5517-P Mail Stop C4-26-05 7500 Security Boulevard Baltimore, MD 21244-1850 Re: Medicare Program; Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive Under the Physician Fee Schedule, and Criteria for PhysicianFocused Payment Models – CMS-5517-P...»

«Package leaflet: Information for the user Sunveniz XL 37.5 mg prolonged-release tablets Sunveniz XL 75 mg prolonged release tablets Sunveniz XL 150 mg prolonged release tablets Venlafaxine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.Keep this leaflet. You may need to read it again.If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to...»

«Scrap Tires in Ciudad Juárez and El Paso: Ranking the Risks Allen Blackman and Alejandra Palma September 2002 • Discussion Paper 02–46 Resources for the Future 1616 P Street, NW Washington, D.C. 20036 Telephone: 202–328–5000 Fax: 202–939–3460 Internet: http://www.rff.org © 2002 Resources for the Future. All rights reserved. No portion of this paper may be reproduced without permission of the authors. Discussion papers are research materials circulated by their authors for purposes...»

«The 25th Annual Waltham/OSU Symposium Small Animal Ophthalmology October 27—28, 2001 Feline Ophthalmology Alexandra van der Woerdt, DVM, MS, DACVO, DECVO Staff Ophthalmologist Associate Director, Bobst Hospital The Animal Medical Center 510 East 62nd Street New York, NY 10021 212-329-8729 212-752-2592 (fax) sandra.vanderwoerdt@amncy.org Ophthalmic examination of a feline patient follows the same principles as ophthalmic examination of the canine patient. A few differences exist between dogs...»





 
<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.